Home » Posts tagged 'novacyt'
Tag Archives: novacyt
Alan Green talks COVID stocks Novacyt #NCYT), Synairgen #SNG, Avacta #AVCT, plus Blue Prism #PRSM & Capita #CPI on the UK Investor Magazine podcast
The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020.
The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating 90% effectiveness. We look at the sharp rally in markets and question the sustainability going forward.
We discuss Novacyt (NCYT), Synairgen (SNG), Avacta (AVCT), Blue Prism (PRSM) and Capita (CPI).
Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA
Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA
Atlantic Capital Markets Month Ahead – July 2020
Alan Green talks to John Woolfitt, Director at multi award winning broking and investment firm Atlantic Capital Markets. John looks forward to the coming month, and discusses US job numbers, Boris and Build Build Build, and the raft of UK job cuts. He then discusses ‘Covid’ stocks, including Novacyt #NCYT, upcoming key corporate announcements for July, including Royal Dutch Shell #RDSB and Hutchison China Meditech #HCM and trading ideas from the Atlantic dealing floor. John finishes with a recap on key points and trading ideas to help traders and investors in July.